Latest Breaking News On - Cure trading down - Page 5 : comparemela.com

Commerce Bank Increases Stock Position in AtriCure, Inc (NASDAQ:ATRC)

Commerce Bank grew its stake in AtriCure, Inc. (NASDAQ:ATRC – Free Report) by 5.6% during the first quarter, according to its most recent 13F filing with the SEC. The firm owned 11,357 shares of the medical device company’s stock after acquiring an additional 602 shares during the period. Commerce Bank’s holdings in AtriCure were worth […]

United statesStifel nicolausKarls dahlquistPiper sandlerJump financialAtricure incEmerald mutual fund advisersAtricure company profileSecurities exchange commissionEssex investment management coBarclays plcNeedham companyAdvisors capital managementCommerce bankFree reportInvestment management

NovoCure (NASDAQ:NVCR) Now Covered by Analysts at SVB Leerink

SVB Leerink assumed coverage on shares of NovoCure (NASDAQ:NVCR – Free Report) in a research report sent to investors on Friday morning, Benzinga reports. The brokerage issued an outperform rating and a $51.00 target price on the medical equipment provider’s stock. NVCR has been the subject of several other reports. SVB Securities started coverage on […]

United statesOptune luaPiper sandlerPanagora asset management incBlackrock incWells fargo companyBlair william coUs bancorpDimensional fund advisorsFree reportCure trading downGet free reportAsset managementFund advisorsBlair williamCure limited

NovoCure (NASDAQ:NVCR) Posts Quarterly Earnings Results, Misses Estimates By $0 04 EPS

NovoCure (NASDAQ:NVCR) Posts Quarterly Earnings Results, Misses Estimates By $0 04 EPS
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

United statesPiper sandlerOptune luaBlackrock incNorges bankPricet rowe associates incVanguard group incSquarepoint opsWells fargo companyGet free reportCure trading downCure limitedMiddle eastNovocure daily

HC Wainwright Trims NovoCure (NASDAQ:NVCR) Target Price to $85 00

NovoCure (NASDAQ:NVCR – Get Rating) had its price target decreased by HC Wainwright from $115.00 to $85.00 in a research report report published on Wednesday morning, The Fly reports. HC Wainwright also issued estimates for NovoCure’s FY2025 earnings at ($3.27) EPS, FY2026 earnings at ($3.32) EPS and FY2027 earnings at ($2.46) EPS. Several other equities […]

Lazard asset managementMcelhenny sheffield capital managementJpmorgan chase coChina universal asset management coHarel insurance investments financial services ltdNovocure ltdWells fargo companyWhittier trust coGet ratingCure trading downElhenny sheffield capital managementAsset managementUniversal asset managementHarel insurance investmentsFinancial servicesInsurance investments

NovoCure Limited (NASDAQ:NVCR) Receives $84 83 Consensus Price Target from Brokerages

NovoCure Limited (NASDAQ:NVCR – Get Rating) has earned an average recommendation of “Hold” from the seven research firms that are currently covering the stock, Marketbeat reports. Two analysts have rated the stock with a sell rating, one has issued a hold rating and two have given a buy rating to the company. The average twelve-month […]

Ashley cordovaBlackrock incNovocure limitedHartline investment corpWells fargo companyNordwand advisorsNovocure ltdJpmorgan chase coPricet rowe associates incNorges bankGet ratingCure trading downTumor treating fieldNovocure dailyNasdaq nvcr